Related Experiment Video
Updated: Sep 13, 2025

Generation of Greater Bacterial Biofilm Biomass using PCR-Plate Deep Well Microplate Devices
Published on: April 22, 2022
Antimicrobial Peptides SET-M33L and SET-M33L-PEG Are Promising Agents Against Strong Biofilm-Forming P. aeruginosa,
Alessio Fontanot1,2,3, Peter D Croughs2, Clelia Cortese4
1Laboratory of Pediatrics, Department of Pediatrics, Sophia Children's Hospital, Erasmus University Medical Center (Erasmus MC), 3015 GD Rotterdam, The Netherlands.
Abstract:
Background: The antimicrobial peptides (AMPs) SET-M33L and SET-M33L-PEG were investigated against 10 clinical isolates of P. aeruginosa. Methods: Their minimum inhibitory concentrations (MICs), minimum bactericidal concentrations (MBCs), and minimum biofilm inhibitory concentrations (MBICs) were evaluated against tobramycin, ceftazidime, and polymyxin B. Results: MICs and MBCs were 7- to 100-fold lower than tobramycin, and 10- to 300-fold lower than ceftazidime. Fractional inhibitory concentration (FIC) indices showed an additive effect, while fractional bactericidal concentration (FBC) indices showed synergistic effects (FBC < 0.5) for most isolates. Conclusion: SET-M33L and SET-M33L-PEG are promising antimicrobial agents against strong biofilm-forming P. aeruginosa, including MDR isolates.
Insights
New antimicrobial peptides (AMPs), SET-M33L and SET-M33L-PEG, show significant potential against Pseudomonas aeruginosa. These agents are effective against drug-resistant strains and biofilms.
Area of Science:
- Microbiology
- Biochemistry
- Pharmacology
Background:
- Pseudomonas aeruginosa is a significant opportunistic pathogen.
- Multidrug-resistant (MDR) P. aeruginosa poses a growing clinical challenge.
- Antimicrobial peptides (AMPs) represent a potential therapeutic avenue.
Purpose of the Study:
- To evaluate the efficacy of novel AMPs, SET-M33L and SET-M33L-PEG.
- To compare their activity against clinical isolates of P. aeruginosa with existing antibiotics.
- To assess their impact on P. aeruginosa biofilm formation.
Main Methods:
- Minimum Inhibitory Concentration (MIC) assays.
- Minimum Bactericidal Concentration (MBC) assays.
- Minimum Biofilm Inhibitory Concentration (MBIC) assays.
- Fractional Inhibitory Concentration (FIC) and Fractional Bactericidal Concentration (FBC) index calculations.
Main Results:
- SET-M33L and SET-M33L-PEG demonstrated significantly lower MICs and MBCs compared to tobramycin and ceftazidime.
- FIC indices indicated additive effects, while FBC indices suggested synergistic effects against most P. aeruginosa isolates.
- The AMPs were effective against strong biofilm-forming P. aeruginosa, including MDR strains.
Conclusions:
- SET-M33L and SET-M33L-PEG exhibit potent antimicrobial activity against P. aeruginosa.
- These AMPs show promise as novel therapeutic agents for biofilm-related infections.
- Their efficacy against MDR isolates warrants further investigation for clinical application.
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Biofilms
Antimicrobial Effectiveness
Biological Methods for Microbial Control

